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Summary  Injections  with  re-used  syringes  have  been  identiﬁed  as  a  major
risk  factor  for  hepatitis  B  virus  (HBV)  and  hepatitis  C  virus  (HCV)  infections  in
Pakistan.  We  analyzed  data  from  the  2006—2007  Pakistan  Demographic  Health  Sur-
vey  (PDHS)  to  describe  the  distribution  of  injections  administered  with  newly  opened
syringes  and  assessed  the  association  of  knowledge  about  bloodborne  pathogens
with  syringe  reuse  in  Pakistan.  In  the  PDHS,  women  aged  12—49  years  were  enrolled
through  a  multistage  stratiﬁed  cluster-sampling  strategy  across  Pakistan.  Approxi-
mately  10,000  women  were  interviewed  to  collect  information  regarding  receiving
injections,  the  use  of  syringes  taken  out  of  new  unopened  packages  for  their
last  injections,  and  knowledge  regarding  the  transmission  of  Human  Immunodeﬁ-
ciency  Virus  (HIV),  HBV  and  HCV  through  the  re-use  of  syringes  and  transfusion
of  unscreened  blood.  Of  the  5126/10,023  women  who  provided  information  con-
cerning  their  last  injection,  4342  (86%)  received  this  injection  with  a  new  syringe
taken  out  of  an  unopened  package.  The  proportion  of  injections  received  with  a  new
syringe  increased  with  the  education  level,  wealth,  HIV  knowledge  and  knowledge
about  HCV/HBV  transmission  through  the  re-use  of  syringes.  In  the  multivariable
model,  respondents  in  the  4th  (adjusted  odds  ratio  (AOR):  2.1,  95%CI:  1.4—3.0)  and
5th  (AOR:  2.4,  95%CI:  1.6—3.5)  wealth  quintiles,  with  some  education  (AOR:  1.4,
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Introduction
High  rates  of  hepatitis  B  virus  (HBV)  and  hepatitis
C virus  (HCV)  infection  in  Pakistan  have  been  well-
documented  in  recent  studies.  The  prevalence  of
HCV based  on  anti-HCV  antibodies  ranges  from  5%
to 25%  in  the  general  population,  and  the  preva-
lence in  high  risk  groups,  such  as  people  who  inject
drugs (PWID)  (8—68%)  and  jail  inmates  (13—18%),
is higher  [1—10].  Similarly,  studies  have  reported  a
high prevalence  of  HBV  based  on  various  markers
of positivity  (anti  HBsAg  antibodies)  in  the  gen-
eral population  (3%)  and  in  high  risk  groups  (>6%)
[4,5,7,10].  The  high  rates  of  HBV  and  HCV  are  cul-
minating  in  a  large  number  of  people  with  chronic
liver disease  and  the  resulting  sequelae,  such  as
liver cirrhosis  and  hepatic  carcinoma  [11,12]. In
addition to  placing  an  increased  burden  on  individ-
uals,  families  and  society  because  of  the  effects
on the  quality  of  life  and  life  expectancy,  these
increased rates  of  chronic  liver  disease  add  to  the
burden  of  an  already  compromised  health  care
system [13].  Although  HIV  prevalence  is low  in
the general  population,  the  prevalence  in  PWID
has increased  from  16%  in  2006  to  37%  in  2012
[14,15].  The  re-use  of  syringes  in  clinics  could
act as  bridge  for  HIV  transmission  between  the
high risk  populations  and  the  general  population
[16].
Since  the  early  1990s,  studies  on  HBV  and  HCV
have identiﬁed  unsafe  medical  injections  —  mainly
the reuse  of  injection  equipment  —  as  a major
risk factor  for  HCV  and  HBV  in  Pakistan  [2,17—21].
Injection use  is  very  common  in  Pakistan,  and  5—11
injections  are  received  per  person  per  year  [22]. A
large number  of  these  injections  are  provided  with
previously  used  injection  equipment  [22]. Syringe
reuse  estimates  vary  from  25%  to  80%  across
various settings  [22—24].  To  reduce  the  number
of injections  given  with  reused  syringes,  studies
have  mainly  focused  on  assessing  the  determinants
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e  4th  quartile  of  the  HIV  knowledge  score  (AOR:  1.5,
ith  the  knowledge  that  a  new  syringe  protects  against
 95%CI:  1.5—3.5)  were  more  likely  to  receive  injections
e.  The  patients’  knowledge  regarding  the  transmission
an  important  factor  in  receiving  injections  with  a  new
blished  by  Elsevier  Limited  on  behalf  of  King  Saud  Bin
th  Sciences.  All  rights  reserved.
f  injection  overuse  [25,26]. Injection  overuse
s driven  by  patient  and  provider  factors,  including
ow awareness  among  patients  about  the  risk  of
BV/HCV  transmission,  beliefs  in  injection  efﬁcacy,
atient  perceptions  that  the  provider  considers  it
ecessary to  administer  injections  and  provider
erceptions that  the  patient  expects  to  be  given
n injection.  Economic  incentives  for  providers
nd a  low  level  of  knowledge  related  to  the
isks associated  with  unnecessary  injections  also
ncrease injection  use  [25,26]. These  factors  make
educing  injection  overuse  complex,  difﬁcult  and
ime consuming  [22,25,26]. Focusing  on  reducing
yringe  reuse  in  the  short  term  might  be  more
onducive to  the  development  of  behavioral  and
tructural  interventions  and  would  have  a  direct
mpact  on  the  incidence  of  infection  associated
ith syringe  reuse.
Understanding  the  factors  driving  the  reuse
f injection  equipment  or  injection  administra-
ion with  a  new  syringe  in  the  population  with
 level  of  knowledge  about  the  transmission  of
BV/HCV could  help  in  designing  interventions
o reduce  reuse  and  reduce  the  incidence  of
nfection. In  healthcare  workers,  we  found  that
ncreased  knowledge  about  HBV/HCV  transmission
s associated  with  better  adherence  with  protec-
ive measures  [27,28]. We  used  data  from  the
akistan  Demographic  and  Health  Survey  (PDHS)
onducted  in  2007  to  assess  factors,  especially
he role  of  knowledge  about  bloodborne  pathogens
BBPs), associated  receiving  injections  with  new
yringes.
ethods
etting and survey designhe  2006—2007  PDHS  was  a nationally  representa-
ive household  survey  conducted  in  Pakistan  [17].
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Figure  1  HIV  transmission  knowledge  score  by  education
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injection  reuse  and  blood  borne  pathogen  knowledg
he  PDHS  is  a  standard  demographic  and  health
urvey focusing  on  women  and  child  health,  includ-
ng nutrition,  immunizations,  child,  maternal  and
dult mortality,  family  planning  and  other  repro-
uctive  health  issues,  malaria,  and  knowledge  on
TIs and  HIV.  More  than  300  similar  surveys  have
een conducted  across  90  countries  [29].  Details  of
he sampling  and  methods  are  provided  in  the  sur-
ey report  [17].  Brieﬂy,  households  were  selected
hrough a  stratiﬁed  two-stage  cluster  survey  design.
he ﬁrst  stage  involved  the  selection  of  927  primary
ampling units  (PSU)  (clusters)  based  on  probabil-
ty proportional  to  the  population  size  within  each
tratum.  The  PSUs  were  census  enumeration  blocks
n urban  areas  and  villages  in  rural  areas.  Each  large
ity formed  its  own  stratum,  and  the  remaining
rban areas  were  considered  a  separate  stratum.
n rural  areas,  each  district  in  the  Punjab,  Sindh,
nd Khyber  Pakhtoon  Khawa  (KPK)  provinces  was
onsidered  as  a  stratum,  and  former  administra-
ive divisions  were  treated  as  a  stratum  in  the
alochistan province.  The  second  stage  involved
he selection  of  households.  In  each  PSU,  105  house-
olds were  selected  through  systematic  sampling,
esulting in  a  total  selection  of  102,060  households.
ut of  105  sampled  households,  10  households  in
ach PSU  were  selected  using  systematic  sampling
o conduct  interviews  for  the  Long  Household  and
he Women’s  Questionnaires,  which  provided  the
ata for  this  analysis.  The  Federally  Administered
orthern Areas  (FANA)  and  restricted  military  and
rotected  areas  were  not  included  in  the  samples.
maller provinces  (Balochistan  and  KPK)  and  urban
reas were  over  sampled.
tudy population
ll  ever-married  women  aged  12—49  years  who
ere usual  residents  of  the  household  or  visitors
n the  household  who  stayed  there  the  night  before
he survey  were  eligible  for  the  interview.
urvey instruments and data
n  our  analysis,  we  used  data  based  on  the  Long
ousehold and  Women’s  Questionnaires.  The  Long
ousehold  Questionnaire  collected  information  on
ousehold members  and  identiﬁed  eligible  ever-
arried  women  aged  12—49  years  for  interview
sing the  Women’s  Questionnaire.  The  Long  House-
old  Questionnaire  was  used  to  collect  information
n the  characteristics  of  the  dwelling  and  house-
old possessions  to  provide  data  for  construction
f the  wealth  index.  The  Women’s  Question-
aire collected  information  from  ever-married
omen aged  12—49  years  on  socio-demographic
t
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haracteristics  (education,  language,  marriage
haracteristics), reproductive  history,  knowledge
nd use  of  family  planning  methods,  prenatal  and
ostnatal  care,  child  immunizations,  health,  nutri-
ion, fertility  preferences,  breastfeeding  practices,
oman’s  work,  husband’s  background  characteris-
ics, awareness  about  HIV/AIDS  and  other  sexually
ransmitted  infections,  other  health  issues  such  as
nowledge  about  tuberculosis  and  hepatitis,  expe-
iences with  ﬁstulas,  and  the  use  of  clean  syringes
or injections.
ariables used in the analysis
ur  main  outcome  variable  was  receiving  the  last
njection  from  a newly  opened  syringe  (corol-
ary to  receiving  the  injection  from  a re-used
yringe) as  inquired  in  the  survey.  The  exposure
ariables included  knowledge  about  HBV,  HCV  and
IV transmission  by  re-used  syringes  and  blood
ransfusions based  on  the  questions  ‘‘Do  you  think
hat one  can  protect  herself/himself  from  get-
ing hepatitis  B,  C,  and  HIV/AIDS  if:  (a)  a syringe
nd needle  from  a  new  unopened  packet  is  used
hile giving  an  injection?  (b)  if  need  be,  blood
ested for  hepatitis  B,  C  and  HIV/AIDS  virus  is
ransfused?’’, and  the  clinical  setting  for  the  last
njection.  The  survey  collected  detailed  informa-
ion on  HIV/AIDS  transmission  knowledge  (Table  1).
e created  a  HIV/AIDS  knowledge  score  based  on
 items  about  HIV  transmission  knowledge;  a score
f 1  was  given  for  each  correct  response  and  0 was
iven for  each  incorrect  response.  Other  variables
ncluded age,  education,  and  socioeconomic  posi-
ion (wealth  index  quintiles),  which  was  based  on
ousehold  assets  and  categorized  into  5  categories
ith  the  5th  being  richest  and  the  1st  being  the
oorest.
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Table  1  Questions  about  HIV/AIDS  and  hepatitis  B  and  C  virus  knowledge  used  in  the  analysis  (Demographic  and
Health  Survey  of  Pakistan,  2006—2007).
Questions  Response
HIV/AIDS  transmission  knowledge
1  Can  people  reduce  their  chance  of  getting  the  AIDS  virus  by
staying  faithful  to  just  one  partner?
Yes, No,  Don’t  know
2  Can  people  get  the  AIDS  virus  from  mosquito  bites?  Yes,  No,  Don’t  know
3  Can  people  reduce  their  chance  of  getting  the  AIDS  virus  by  using
a  condom  every  time  they  have  sex?
Yes,  No,  Don’t  know
4  Can  people  get  the  AIDS  virus  by  sharing  food  with  a  person  who
has  AIDS?
Yes, No,  Don’t  know
5  Can  people  reduce  their  chance  of  getting  the  AIDS  virus  by  not
having  sexual  intercourse  at  all?
Yes, No,  Don’t  know
6  Can  the  virus  that  causes  AIDS  be  transmitted  from  a  mother  to  a
child:
6a  During  pregnancy?  Yes,  No,  Don’t  know
6b  During  delivery?  Yes,  No,  Don’t  know
6c  By  breastfeeding?  Yes,  No,  Don’t  know
Hepatitis  B,  C,  and  HIV  AIDS  prevention  knowledge
7  Do  you  think  that  one  can  protect  herself/himself  from  getting
Hepatitis  B,  C,  and  HIV  AIDS  if:
7a  A  syringe  and  needle  from  a  new  unopened  packet  is  used  while
giving  an  injection?
Yes, No,  Don’t  know
7b  If  need  be,  blood  tested  for  Hepatitis  B,  C  and  HIV/AIDS  virus  is Yes,  No,  Don’t  know
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Questions 1—6 used for constructing the HIV related knowledg
Statistical analysis
We  described  the  distribution  of  the  participant
proﬁle by  computing  proportions  for  the  categori-
cal variables  and  means/medians  for  the  continuous
variables  while  accounting  for  the  cluster  sampling
design and  applying  sampling  weights  using  the  sur-
vey modules  in  SAS  9.2  (Cary,  NC,  United  States).
The computation  of  sampling  weights  is described
in the  survey  report.  We  computed  the  proportion
and corresponding  95%  conﬁdence  intervals  of  the
participants  receiving  injections  with  newly  opened
syringes.  We  computed  the  crude  and  adjusted  odds
ratios to  assess  the  associations  between  the  socio-
demographic  and  knowledge  related  factors  with
receiving  injections  with  newly  opened  syringes
using proc  survey  logistic  while  accounting  for  the
complex  survey  design.
Results
Participant proﬁle
Overall  data  from  10,023  women  were  available
for the  analysis.  The  mean  (SE)  age  of  women  was
32.4 (0.11)  years  [median:  31;  range:  15—49].  The
age group  of  20—29  years  comprised  the  largest
percentage (35%)  followed  by  30—39  years  (34%).
i
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pproximately  65%  of  the  women  had  no  formal
chooling, 14%  completed  secondary  school  and
% had  an  education  level  higher  than  secondary
chool. The  education  level  was  associated  with
ealth;  28%  of  those  with  no  education  were  the
oorest  and  8%  were  the  richest,  and  <1%  of  those
ith >10th  grade  education  were  the  poorest  and
8% were  the  richest  (Table  2).
In total,  76%  and  69%  of  the  participants
eported  protection  from  BBPs  by  the  use  of  a  new
yringe  and  transfusions  of  screened  blood,  respec-
ively. A  more  comprehensive  knowledge  about
IV transmission  was  lower;  59%  did  not  correctly
dentify any  mode  of  HIV  transmission,  17%  cor-
ectly  answered  1—3  items  and  24%  answered  4—8
tems  correctly.  The  maximum  knowledge  score  was
orrect responses  to  6 items  out  of  8,  and  8%  respon-
ents  received  the  maximum  score.  Three  quarters
76%) of  those  without  formal  schooling  did  not  cor-
ectly identify  any  mode  of  transmission,  and  12%
orrectly  identiﬁed  4—6  items.  Of  the  women  with
n education  level  beyond  secondary  school,  6%  did
ot correctly  identify  any  items,  and  64%  identiﬁed
 items  (Fig.  1).
Approximately  half  (n  =  5180,  53%)  of  the  partic-pants received  at  least  one  injection  during  past
ne year,  and  5126  provided  information  on  the
ast injection,  all  of  which  received  during  the  past
ear. This  group  contributed  to  the  further  analysis
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anjection  reuse  and  blood  borne  pathogen  knowledg
f  receiving  an  injection  with  a  newly  opened
yringe. The  distributions  of  age,  education  and
nowledge  were  similar  in  this  group  and  in  the
verall sample.  Similar  to  the  overall  sample,  in
his group,  large  percentage  of  respondents,  81%
nd 73%,  reported  BBP  protection  by  the  use  of  a
ew syringe  and  transfusions  of  screened  blood.
he in-depth  knowledge  about  HIV  transmission  in
his group  was  poor;  55%  did  not  correctly  identify
ny mode  of  HIV  transmission,  17%  correctly
nswered 1—3  items  and  28%  correctly  answered
—8 items.  The  HIV  transmission  knowledge  score
aried  by  education  level.  Of  the  respondents  with
o formal  schooling,  73%  did  not  correctly  identify
ny items,  and  15%  answered  4—6  items  correctly.
f the  respondents  with  more  than  secondary
chool education,  5%  did  not  correctly  identify  any
tem, and  65%  correctly  identiﬁed  4—6  items.
istribution of injections with new syringes
f  the  5126  women  who  provided  information
bout their  last  injection,  86%  received  injections
ith new  syringes  taken  out  of  unopened  pack-
ges, 4%  received  injections  with  previously  used
yringes  and  10%  did  not  know  the  status  of  the
yringe. The  percentage  of  those  who  reported
eceiving injections  with  a  newly  opened  syringe
ncreased with  the  education  level,  knowledge
bout protection  from  BBP  transmission  by  use  of
 new  syringe,  wealth,  and  HIV  transmission  knowl-
dge score  (Table  2).  The  percentage  of  injections
eceived using  a  new  syringe  differed  by  knowl-
dge about  protection  from  BBP  transmission  across
he level  of  education.  Among  those  without  for-
al schooling,  69%  of  those  who  reported  ‘‘no’’
o protection  against  HCV/HBV  by  the  use  of  a
ew syringe  reported  receiving  injections  with  a
ewly opened  syringe,  compared  with  89%  of  those
ho reported  ‘‘yes’’  (P  <  0.001);  these  percentages
ere 87%  and  94%  among  the  women  with  any
ducation (P  <  0.001).  The  distribution  of  injections
dministered  with  a  new  syringe  differed  by  wealth
ithin  the  level  of  education.  Among  those  with  no
ducation,  72%  of  the  poorest  and  89%  of  the  rich-
st reported  receiving  injections  with  new  syringes,
nd these  proportions  were  89%  (poorest)  and  93%
richest)  among  those  with  any  education  (P  =  0.01).
actors for receiving injections with new
yringesable  3 shows  the  unadjusted  odds  ratios  for  vari-
us factors  associated  with  receiving  an  injection
ith a  new  syringe.  In  the  multivariable  logistic
o
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t
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egression  model  (Table  4), accounting  for  samp-
ing design,  wealth,  education,  knowledge  about
he prevention  of  BBP  transmission  by  the  use  of
 new  syringe,  and  HIV  transmission  knowledge
core were  signiﬁcantly  associated  with  receiving
n injection  with  a  newly  opened  syringe.  Those
ho reported  knowledge  about  the  protection  from
BPs by  the  use  of  a new  syringe  were  twice
s likely  to  receive  injections  with  newly  opened
yringes (AOR:  2.3,  95%CI:  1.5—3.5)  compared  with
hose without  this  knowledge.  Those  in  the  4th
uartile  of  the  HIV  transmission  knowledge  score
ere more  likely  to  receive  injections  with  newly
pened syringes  (AOR:  1.5,  95%CI:  1.1—2.0)  than
hose in  the  1st  quartile.  Those  with  some  edu-
ation  were  more  likely  to  receive  injections  with
ewly  opened  syringes  (AOR:  1.4;  95%CI:  1.1—1.9).
hose  in  the  4th  (richer)  (adjusted  odds  ratio  (AOR):
.1, 95%CI:  1.4—3.0)  and  5th  (richest)  (AOR:  2.4,
5%CI: 1.6—3.5)  wealth  quintiles  were  more  likely
o receive  injections  with  newly  opened  syringes
han those  in  the  1st  quintile  (poorest).
iscussion
e  used  a nationally  representative  sample  of
akistani  women  to  assess  whether  knowledge
bout BBPs  impacts  receiving  injections  with  newly
pened syringes.  We  found  that  a large  per-
entage of  women  knew  that  an  injection  with
 new  syringe  and  transfusions  with  screened
lood protects  against  BBPs,  but  the  knowledge
bout various  HIV  transmission  modes  was  low.
he majority  of  injections  (86%)  were  provided
ith newly  opened  syringes.  Knowledge  about
rotection against  BBPs  with  the  use  of  a  new
yringe, higher  HIV  knowledge,  and  being  in  the
th(richer)  or  5th  quintiles  (richest)  of  the  wealth
ndex were  associated  with  receiving  injections
ith new  syringes.  These  ﬁndings  have  important
mplications for  the  prevention  of  HBV  and  HCV
ransmission  and  the  transmission  of  HIV  from  high-
isk groups  to  the  low  risk  general  population
hrough the  re-use  of  syringes  in  healthcare  settings
n Pakistan.
Pakistan  has  a very  high  prevalence  of  HBV
nd HCV.  Studies  have  shown  that  the  majority
f HCV  and  HBV  transmission  is  attributed  to  the
e-use of  syringes  for  infections  [2,4,5,18—21].  In
akistan, a  large  number  of  injections  are  received,
nd studies  have  reported  that  a  large  proportion
f these  injections  are  provided  with  previously
sed syringes  [22—24]. In  this  situation,  reducing
he overall  injection  use  and  reducing  the  reuse
f syringes  should  reduce  the  incidence  of  HCV
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Table  2  Participant  proﬁle  and  distribution  of  injections  with  new  syringes  (Demographic  and  Health  Survey  of
Pakistan,  2006—2007).
All  participants  Received  injection  Injection  with  new  syringe
Variables  N  (%)  N  (%)  N  (%)
Province
Punjab  4263  (58)  2168  (56)  1964  (91)
Sindh  2716  (24)  1798  (30)  1329  (74)
Khyber  Pakhtoon  Khawa  1862  (13)  953  (13)  887  (93)
Balochistan  1182  (5)  207  (2)  162  (76)
Area
Capital,  large  city  1929  (19)  1032  (19)  940  (91)
Small  city  1539  (12)  764  (12)  669  (88)
Town 362  (2) 153  (2) 128  (82)
Countryside  6193  (67)  3177  (66)  2605  (84)
Age  (years)
15—19  578  (6)  308  (6)  234  (78)
20—29  3570  (35)  1972  (38)  1674  (87)
30—39 3365  (34)  1660  (33)  1428  (87)
40—49 2510  (25) 1186  (23)  1006  (85)
Highest  educational  level
No  education 6665  (65) 3263  (62)  2617  (82)
Primary 1344  (14) 789  (17) 717  (92)
Secondary  1348  (14) 747  (15)  696  (93)
Higher  666  (6) 327  (6) 312  (95)
Wealth  index
Poorest  (1st  quintile) 1956  (19) 929  (18) 654  (73)
Poorer 2036  (20) 981  (19) 789  (83)
Middle  1946  (19) 1011  (20) 857  (86)
Richer  2028  (21)  1114  (22)  1020  (92)
Richest  (5th  quintile)  2057  (21)  1091  (21)  1022  (94)
Knowledge  on  protection  against  HCV/HBV  and  HIV  by  using  new  syringe/needle
No  392  (4)  157  (3)  110  (76)
Yes  7336  (76)  4068  (81)  3615  (90)
Don’t  know  2197  (20)  866  (16)  592  (70)
Knowledge  on  protection  against  HCV/HBV  and  HIV  by  testing  blood  before  transfusion
No  473  (5)  202  (4)  164  (83)
Yes  6735  (69)  3736  (73)  3300  (89)
Don’t  know  2717  (26)  1150  (22)  850  (76)
HIV  knowledge  score
0  (1st  and  2nd  quartile)  5960  (59)  2807  (54)  2200  (80)
1—3  (3rd  quartile)  1664  (17)  882  (17)  796  (90)
4—8  (4th  quartile)  2399  (24)  1437  (28)  1346  (94)
Source  of  syringe  for  last  injection
Public  898  (17)  768  (88)
Private  hospital/clinic/private  dental  clinic  2621  (52)  2118  (82)
Chemist/other  private  732  (14)  697  (95)
i
n
I
h
IPrivate  dispenser/compounder  
and  HBV  in  Pakistan.  Efforts  have  been  devoted
to understanding  and  assessing  interventions  to
reduce the  overall  injection  use.  Injection  use  is
driven by  provider  and  patient  beliefs  in  injec-
tion efﬁcacy  [22,25,26]. Interventions  to  bridge  the
gap between  the  understanding  of  patients  and
providers  regarding  injection  use,  called  interac-
tional  group  discussions  (IGD),  have  been  proposed.
These  interventions  have  been  shown  to  reduce
s
a
k
i830  (16)  723  (87)
njection  use  in  controlled  trial  settings  but  have
ot been  scaled-up  to  a  pragmatic  level  [30—32].
GDs might  also  reduce  injection  re-use,  though  this
as not  been  assessed.  The  basic  assumption  behind
GD success  is  empowerment,  with  some  level  of
elf-efﬁcacy  and  knowledge  about  the  risk  associ-
ted with  injections.  Here,  we  showed  that  a  higher
nowledge  about  BBPs  is  associated  with  receiving
njections  with  newly  opened  syringes.  Knowledge
Injection  reuse  and  blood  borne  pathogen  knowledge  351
Table  3  Crude  odds  ratio  for  associations  with  receiving  injections  with  newly  opened  syringes  (Demographic  and
Health  Survey  of  Pakistan,  2006—2007).
Variables  n/N  OR  (95%CI)
Province
Punjab  1964/2168  1.0
Sindh  1329/1798  1.1  (1.0—1.3)
Khyber  Pakhtoon  Khawa  887/953  1  (0.9—1.2)
Balochistan  162/207  0.2  (0.1—0.2)
Area
Capital,  large  city  940/1032  1.0
Small  city  669/764  0.9  (0.8—1.0)
Town  128/153  0.6  (0.4—0.8)
Countryside  2605/3177  0.8  (0.7—0.9)
Age  (years)
15—19  234/308  1.0
20—29  1674/1972  1.4  (1.1—1.7)
30—39  1428/1660  1.1  (0.9—1.3)
40—49 1006/1186  1.0  (0.8—1.2)
Highest  educational  level
No  education 2617/3263  1.0
Primary 717/789  1.9  (1.6—2.1)
Secondary  696/747  1.6  (1.4—1.8)
Higher  312/327  1.3  (1.1—1.6)
Highest  educational  level
No  education 2617/3263  1.0
Some  education 1725/1863  1.6  (1.5—1.8)
Wealth  index
Poorest  (1st  quintile) 654/929  1.0
Poorer  789/981  1.2  (1.0—1.5)
Middle  857/1011  1.6  (1.4—1.9)
Richer  1020/1114  1.9  (1.6—2.2)
Richest  (5th  quintile)  1022/1091  1.9  (1.6—2.2)
Knowledge  on  protection  against  HCV/HBV  and  HIV  by  using  new  syringe/needle
No  110/157  1.0
Yes  3615/4068  2.4  (1.8—3.2)
Don’t  know  592/866  1.0  (0.8—1.3)
Knowledge  on  protection  against  HCV/HBV  and  HIV  by  testing  blood  before  transfusion
No  164/202  1.0
Yes  3300/3736  1.9  (1.5—2.5)
Don’t  know  850/1150  1.0  (0.8—1.3)
HIV  knowledge  score
0  (1st  and  2nd  quartile)  2200/2807  1.0
1—3  (3rd  quartile)  796/882  1.5  (1.3—1.8)
4—8  (4th  quartile)  1346/1437  2.1  (1.8—2.3)
Source  of  syringe  for  last  injection
Public  clinic  768/898  1.0
Private  hospital/clinic/private  dental  clinic  2118/2621  0.7  (0.5—0.8)
Chemist/other  private  697/732  2.7  (1.7—4.2)
Private  Dispenser/compounder 723/830  1.0  (0.7—1.4)
i
c
i
t
w
a
a
ps  the  ﬁrst  step  in  increasing  risk  perception  asso-
iated  with  re-used  syringes  that  could  compel
ndividuals to  take  action.  We  previously  showed
hat knowledge  of  BBP  transmission  was  associated
ith increased  use  of  universal  precautions  (UPs)
nd a  lower  incidence  of  needle  stick  injuries  (NSIs)
t
i
among  health  care  workers  [27,33,34].  A  similar  risk
erception model  could  also  explain  the  associa-
ion between  knowledge  about  BBPs  and  receiving
njections with  new  syringes  in  the  population.
In this  study,  knowledge  regarding  protection
gainst HCV/HBV  and  HIV  transmission  by the  use
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Table  4  Multivariable  models  for  factors  associated  with  receiving  an  injection  with  a  newly  opened  syringe
(Demographic  and  Health  Survey  of  Pakistan,  2006—2007).
Full  model  Selected  model
Variables  n/N  AdjOR  (95%CI)  AdjOR  (95%CI)
Province
Punjab  1964/2168  1.0 1.0
Sindh  1329/1798  0.4  (0.3—0.4)  0.3  (0.3—0.4)
Khyber  Pakhtoon  Khawa  887/953  1.3  (0.8—1.9)  1.3  (0.8—1.9)
Balochistan  162/207  0.4  (0.3—0.7)  0.4  (0.3—0.7)
Area
Capital,  large  city  940/1032  1.0
Small  city  669/764  1.0  (0.7—1.6)
Town 128/153  0.7  (0.4—1.6)
Countryside  2605/3177  1.1  (0.7—1.8)
Age  (years)
15—19  234/308  1.0
20—29  1674/1972  1.4  (0.9—2.1)
30—39 1428/1660  1.5  (1—2.1)
40—49 1006/1186  1.3  (0.9—1.9)
Highest  educational  level
No  education 2617/3263  1.0  1.0
Some  education 1725/1863  1.4  (1.1—1.9) 1.4  (1.1—1.9)
Wealth  index
Poorest  (1st  quintile) 654/929  1.0 1.0
Poorer 789/981  1.3  (1.0—1.8) 1.3  (1.0—1.7)
Middle  857/1011  1.3  (1.0—1.8) 1.3  (0.9—1.7)
Richer  1020/1114  2.2  (1.5—3.3) 2.1  (1.4—3.0)
Richest  (5th  quintile) 1022/1091  2.6  (1.6—4.1) 2.4  (1.6—3.5)
Knowledge  on  protection  against  HCV/HBV  and  HIV  by  using  new  syringe/needle
No  110/157  1.0  1.0
Yes  3615/4068  2.4  (1.5—3.9)  2.3  (1.5—3.5)
Don’t  know  592/866  1.0  (0.6—1.6)  1.0  (0.7—1.5)
Knowledge  on  protection  against  HCV/HBV  and  HIV  by  testing  blood  before  transfusions
No  164/202  1.0
Yes  3300/3736  0.9  (0.5—1.5)
Don’t  know  850/1150  0.9  (0.5—1.7)
HIV  knowledge  score
0  (1st  and  2nd  quartile)  2200/2807  1.0  1.0
1—3  (3rd  quartile)  796/882  1.1  (0.8—1.5)  1.1  (0.8—1.5)
4—8  (4th  quartile)  1346/1437  1.5  (1.1—2.1)  1.5  (1.1—2.0)
Source  of  syringe  for  last  injection
Public  clinic  768/898  1.0  1.0
Private  hospital/clinic/dental  clinic  2118/2621  0.6  (0.5—0.8)  0.6  (0.5—0.8)
Chemist/other  private  697/732  2.4  (1.5—3.8)  2.4  (1.5—3.8)
Private  dispenser/compounder  723/830  0.7  (0.5—1.0)  0.7  (0.5—1.0)
h
a
r
t
t
iof  a  new  syringe  was  comparatively  higher  than  in
previous  studies  from  Pakistan,  even  higher  than
in health  care  workers  [27,34—36].  However,  a
more comprehensive  knowledge  about  HIV  trans-
mission  that  included  questions  on  both  correct  and
incorrect  modes  of  transmission  was  lower.  This
suggests  that  actual  knowledge  that  could  translate
into  preventive  action  might  be  lower,  and  ques-
tions  regarding  the  protection  against  HCV/HBV
and HIV  transmission  by  use  of  new  syringe  might
t
a
l
save  been  affected  by  some  level  of  social  desir-
bility, in  which  the  respondent  selected  ‘‘yes’’
esponse  to  please  the  interviewer  and  to  show
hat they  are  knowledgeable.  Even  if  we  assume
hat there  was  some  level  of  measurement  error
n this  question  and  that  multiple  items  on  HIV
ransmission  more  accurately  reﬂected  the  over-
ll knowledge,  there  was  an  association  of  a  high
evel of  HIV  knowledge  with  the  use  of  new  syringes,
uggesting that  knowledge  does  affect  receiving  an
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Rnjection  reuse  and  blood  borne  pathogen  knowledg
njection  with  a  new  syringe.  Because  knowledge
s an  important  predictor  of  receiving  injections
ith new  syringes,  further  work  is  needed  to
evelop validated  tools  to  measure  knowledge
hile avoiding  the  inﬂuences  of  social  desirabil-
ty.
To improve  the  safety  of  medical  injections,
fforts are  needed  to  improve  the  knowledge  level
egarding  BBP  transmission,  prevention  and  the
atural history  of  disease.  Knowledge  is  the  basic
oundation  for  increased  risk  perception  that  might
esult in  action,  which  in  this  case  is receiving
njections with  new  syringes.  Knowledge  might  also
ncrease self-efﬁcacy,  resulting  in  a  demand  for  a
ew syringe.  In-depth  studies  involving  the  use  of
ehavioral  theories  including  items  regarding  risk
erception,  social  norms,  cultural  factors,  barriers,
atient—provider  communication,  and  self-efﬁcacy
re needed  to  understand  how  knowledge  trans-
ates into  the  use  of  new  syringes  and  eventual
educed injection  use.  These  studies  could  provide
 framework  for  behavior  change  strategies  to
educe syringe  reuse  and  reduce  the  incidence  of
BPs. Such  frameworks  have  been  proposed  for
nterventions  to  reduce  the  incidence  of  HBV/HCV
37,38].
The distribution  of  HIV  knowledge  scores  and
nowledge about  protection  against  BBPs  with  the
se of  a  new  syringe  across  the  different  levels
f education  suggests  that  knowledge  is associated
ith the  education  level.  The  effect  of  knowledge
as more  pronounced  among  the  individuals  with
ny level  of  education;  educated  women  had  higher
nowledge  scores.  Educated  individuals  might  be
ore receptive  to  knowledge,  knowledge  might  be
ore accessible  to  them,  or  education  might  have
ncreased  their  overall  general  knowledge.  Efforts
re needed  to  increase  the  knowledge  of  those  with
o/low  education.
Education  is  associated  with  higher  incomes.
igher income  and  education  are  associated  with
igher social  status,  empowerment  and  increased
elf-efﬁcacy.  Given  the  disparity  in  the  level  of
ower distribution  in  the  patient—health  care
rovider relationship  in  developing  countries
specially in  rural  areas,  uneducated  individuals
ho might  have  lower  income  and  social  status
ight be  more  vulnerable  to  receiving  injections
ith re-used  syringes.  This  puts  these  patients
t a  higher  risk  of  acquiring  BBPs.  We  found  that
articipants in  the  lower  wealth  quintiles  were
ess likely  to  receive  injections  with  newly  opened
yringes. Further  investigations  are  needed  to
nderstand  the  relationship  of  education,  wealth
nd social  status  with  knowledge,  and  receiving
njections with  new  syringes  because  interventions353
or  people  with  high  education  levels  might  be
ifferent  from  interventions  targeting  uneducated
eople or  people  with  lower  levels  of  education.
his approach  could  start  with  testing  interventions
or increasing  knowledge,  risk  perception  about
BPs and  self-efﬁcacy  in  demanding  safe  injection
ractices in  a  healthcare  encounter.
These data  provide  important  information  about
he role  of  knowledge  regarding  BBP  transmis-
ion and  receiving  injections  with  new  syringes
rom a large  nationally  representative  sample.
owever, the  current  analysis  was  based  on  cross-
ectional  data  with  further  potential  measurement
rrors from  using  a few  direct  questions  to  assess
nowledge. The  consistent  relationship  with  HIV
nowledge  and  knowledge  with  other  indicators
ndicates the  robustness  of  these  ﬁndings,  but  more
n-depth investigations  including  other  components
f behavior  change  models  would  be  useful  in
ncreasing the  knowledge  base  and  in  developing
peciﬁc program  actions.
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